150 related articles for article (PubMed ID: 20801034)
1. Natural product derivatives with bactericidal activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
Phillips JB; Smith AE; Kusche BR; Bessette BA; Swain PW; Bergmeier SC; McMills MC; Wright DL; Priestley ND
Bioorg Med Chem Lett; 2010 Oct; 20(19):5936-8. PubMed ID: 20801034
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
3. Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.
Ji C; Lin W; Moraski GC; Thanassi JA; Pucci MJ; Franzblau SG; Möllmann U; Miller MJ
Bioorg Med Chem; 2012 Jun; 20(11):3422-8. PubMed ID: 22560837
[TBL] [Abstract][Full Text] [Related]
4. N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Opoku-Temeng C; Naclerio GA; Mohammad H; Dayal N; Abutaleb NS; Seleem MN; Sintim HO
Eur J Med Chem; 2018 Jul; 155():797-805. PubMed ID: 29957525
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidine bis-cyclic guanidines with antimicrobial activity against drug-resistant Gram-positive pathogens identified from a mixture-based combinatorial library.
Hensler ME; Bernstein G; Nizet V; Nefzi A
Bioorg Med Chem Lett; 2006 Oct; 16(19):5073-9. PubMed ID: 16890437
[TBL] [Abstract][Full Text] [Related]
6. Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II).
Cheng C; Liu Y; Song H; Pan L; Li J; Qin Y; Li R
Mar Drugs; 2013 Aug; 11(8):2927-48. PubMed ID: 23955285
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013.
Karlowsky JA; Walkty AJ; Baxter MR; Adam HJ; Zhanel GG
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):311-5. PubMed ID: 25294303
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal Activity and Synergy Studies of Peptide AP-CECT7121 Against Multi-resistant Bacteria Isolated from Human and Animal Soft Tissue Infections.
Delpech G; Bistoletti M; Ceci M; Lissarrague S; Bruni SS; Sparo M
Probiotics Antimicrob Proteins; 2017 Sep; 9(3):355-362. PubMed ID: 28573492
[TBL] [Abstract][Full Text] [Related]
10. Oxygenated elansolid-type of polyketide spanned macrolides from a marine heterotrophic Bacillus as prospective antimicrobial agents against multidrug-resistant pathogens.
Kizhakkekalam VK; Chakraborty K; Joy M
Int J Antimicrob Agents; 2020 Mar; 55(3):105892. PubMed ID: 31926284
[TBL] [Abstract][Full Text] [Related]
11. Amphipathic sulfonamidobenzamides mimicking small antimicrobial marine natural products; investigation of antibacterial and anti-biofilm activity against antibiotic resistant clinical isolates.
Igumnova EM; Mishchenko E; Haug T; Blencke HM; Sollid JUE; Fredheim EGA; Lauksund S; Stensvåg K; Strøm MB
Bioorg Med Chem; 2018 Sep; 26(17):4930-4941. PubMed ID: 30185388
[TBL] [Abstract][Full Text] [Related]
12. Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus.
Al-Qawasmeh RA; Huesca M; Nedunuri V; Peralta R; Wright J; Lee Y; Young A
Bioorg Med Chem Lett; 2010 Jun; 20(12):3518-20. PubMed ID: 20483613
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimicrobial activity of small cationic amphipathic aminobenzamide marine natural product mimics and evaluation of relevance against clinical isolates including ESBL-CARBA producing multi-resistant bacteria.
Igumnova EM; Mishchenko E; Haug T; Blencke HM; Sollid JUE; Fredheim EGA; Lauksund S; Stensvåg K; Strøm MB
Bioorg Med Chem; 2016 Nov; 24(22):5884-5894. PubMed ID: 27692769
[TBL] [Abstract][Full Text] [Related]
14. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.
Nicas TI; Mullen DL; Flokowitsch JE; Preston DA; Snyder NJ; Stratford RE; Cooper RD
Antimicrob Agents Chemother; 1995 Nov; 39(11):2585-7. PubMed ID: 8585753
[TBL] [Abstract][Full Text] [Related]
15. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
16. Isolation and Structural Elucidation of Brevibacillin, an Antimicrobial Lipopeptide from Brevibacillus laterosporus That Combats Drug-Resistant Gram-Positive Bacteria.
Yang X; Huang E; Yuan C; Zhang L; Yousef AE
Appl Environ Microbiol; 2016 May; 82(9):2763-2772. PubMed ID: 26921428
[TBL] [Abstract][Full Text] [Related]
17. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
19. Pharmacodynamic activity of the lantibiotic MU1140.
Ghobrial OG; Derendorf H; Hillman JD
Int J Antimicrob Agents; 2009 Jan; 33(1):70-4. PubMed ID: 18835136
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activity of 11,12-carbamate-3-O-acyl erythromycin derivatives.
Xu P; Liu L; He W; Li Y; Liu J; Lei PS
J Asian Nat Prod Res; 2009 Oct; 11(10):880-97. PubMed ID: 20183250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
